Medicines Act Welcomed, Access Issues Raised

The Critical Medicines Act has been praised by the pharmaceutical industry, particularly the generics lobby, who see it as a positive move to stabilize drug supply chains. However, patient advocacy groups have expressed concerns about potential barriers to access for patients. This highlights a potential conflict between industry interests and patient needs regarding medication availability.

Summarized from the sources above. Read the originals for the full story.